Codexis (CDXS)

Add to Watchlists
Create an Alert
1.77 +0.11  +6.63% NASDAQ Apr 16, 8:00PM BATS Real time Currency in USD
View Full Chart
CDXS Price Chart
View All Events

CDXS Events

Date Type Description
Mar 11 Misc Q4 2013 Codexis, Inc. Earnings Conference Call
Mar 11 Earnings Q4 2013 Codexis, Inc. Earnings Results. Estimate: -0.29.
Nov 12 Misc Codexis to Announce Third Quarter 2013 Financial Results Call
Nov 12 Earnings Codexis to Announce Third Quarter 2013 Financial Results on November 12, 2013. Estimate: -0.30.
Aug 07 Misc Q2 2013 Earnings Release and Conference Call
Aug 07 Earnings Codexis to Announce Second Quarter 2013 Financial Results on August 7, 2013. Estimate: -0.28.
Jun 12 Misc AGM Event for Codexis Inc.
May 07 Misc Q1 2013 Codexis, Inc. Earnings Conference Call
May 07 Earnings Codexis to Announce First Quarter 2013 Financial Results on May 7, 2013. Estimate: -0.22.
View All Performance Charts

CDXS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Codexis is down 14.08% over the last year vs S&P 500 Total Return up 22.52%, Celladon up N/A, and Dyadic International down 6.25%.

Get Quote for

Portfolio Strategies Featuring CDXS

Did Codexis make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CDXS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

Codexis, Inc. is a developer of proprietary biocatalysts, which are enzymes or microbes that initiate or accelerate chemical reactions. It has recently started to use its technology to develop biocatalysts for use in the fine chemicals markets.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CDXS 1.77 +0.11 +6.63% 67.96M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.